Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

BUY
$0.54 - $1.17 $145 - $315
270 New
270 $0
Q1 2023

May 05, 2023

BUY
$0.39 - $0.65 $1,577 - $2,628
4,044 New
4,044 $1,000
Q2 2022

Jul 22, 2022

BUY
$1.05 - $1.39 $4,246 - $5,621
4,044 New
4,044 $4,000

Others Institutions Holding VCNX

About VACCINEX, INC.


  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $240M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Financial Connections Group, Inc. Portfolio

Follow Financial Connections Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Connections Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Connections Group, Inc. with notifications on news.